Antimuscarinique (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antimuscarinique" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
1,538th place
2,720th place
4,294th place
4,303rd place
11th place
325th place

doi.org

dx.doi.org

  • Sanagapalli, Agnihotri, Leong et Corte, « Antispasmodic drugs in colonoscopy: A review of their pharmacology, safety and efficacy in improving polyp detection and related outcomes », Therapeutic Advances in Gastroenterology, vol. 10, no 1,‎ , p. 101–113 (PMID 28286563, PMCID 5330606, DOI 10.1177/1756283X16670076)
  • Mirakhur, « Preanaesthetic medication: a survey of current usage », Journal of the Royal Society of Medicine, vol. 84, no 8,‎ , p. 481–483 (PMID 1886116, PMCID 1293378, DOI 10.1177/014107689108400811)
  • « Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics », Biochem. Pharmacol., vol. 45, no 11,‎ , p. 2352–4 (PMID 8100134, DOI 10.1016/0006-2952(93)90211-e)
  • « Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland », Life Sci., vol. 64, no 25,‎ , p. 2351–8 (PMID 10374898, DOI 10.1016/s0024-3205(99)00188-5)
  • « Binding profile of the selective muscarinic receptor antagonist tripitramine », Eur. J. Pharmacol., vol. 268, no 3,‎ , p. 459–62 (PMID 7805774, DOI 10.1016/0922-4106(94)90075-2)
  • « Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes », Pharmacotherapy, vol. 19, no 4,‎ , p. 447–51 (PMID 10212017, DOI 10.1592/phco.19.6.447.31041)
  • « Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications », Sleep Med Rev, vol. 17, no 4,‎ , p. 263–72 (PMID 23357028, DOI 10.1016/j.smrv.2012.08.001)
  • « Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram », Eur. J. Pharmacol., vol. 576, nos 1–3,‎ , p. 55–60 (PMID 17850785, PMCID 2231336, DOI 10.1016/j.ejphar.2007.08.017)
  • « Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor », J. Pharmacol. Exp. Ther., vol. 318, no 2,‎ , p. 657–65 (PMID 16675639, DOI 10.1124/jpet.106.103382, lire en ligne)
  • « Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo », Psychopharmacology, vol. 205, no 1,‎ , p. 119–28 (PMID 19337725, PMCID 2821721, DOI 10.1007/s00213-009-1521-8)
  • « Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology », Neuropsychopharmacology, vol. 28, no 8,‎ , p. 1400–11 (PMID 12784105, DOI 10.1038/sj.npp.1300203)
  • « Muscarinic mechanisms of antipsychotic atypicality », Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 27, no 7,‎ , p. 1125–43 (PMID 14642972, DOI 10.1016/j.pnpbp.2003.09.008)
  • « Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium », Eur. J. Pharmacol., vol. 390, no 3,‎ , p. 245–8 (PMID 10708730, DOI 10.1016/s0014-2999(00)00037-6)
  • « Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes », Biochem. Pharmacol., vol. 65, no 3,‎ , p. 435–40 (PMID 12527336, DOI 10.1016/s0006-2952(02)01515-0)
  • « Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders », Neuropsychopharmacology, vol. 25, no 6,‎ , p. 904–14 (PMID 11750183, DOI 10.1016/S0893-133X(01)00285-8)
  • « H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs », Neuropsychopharmacology, vol. 28, no 3,‎ , p. 519–26 (PMID 12629531, DOI 10.1038/sj.npp.1300027)
  • « Radioreceptor binding profile of the atypical antipsychotic olanzapine », Neuropsychopharmacology, vol. 14, no 2,‎ , p. 87–96 (PMID 8822531, DOI 10.1016/0893-133X(94)00129-N)

drugbank.ca

  • « Doxylamine », www.drugbank.ca (consulté le )

nih.gov

ncbi.nlm.nih.gov

  • Sanagapalli, Agnihotri, Leong et Corte, « Antispasmodic drugs in colonoscopy: A review of their pharmacology, safety and efficacy in improving polyp detection and related outcomes », Therapeutic Advances in Gastroenterology, vol. 10, no 1,‎ , p. 101–113 (PMID 28286563, PMCID 5330606, DOI 10.1177/1756283X16670076)
  • Mirakhur, « Preanaesthetic medication: a survey of current usage », Journal of the Royal Society of Medicine, vol. 84, no 8,‎ , p. 481–483 (PMID 1886116, PMCID 1293378, DOI 10.1177/014107689108400811)
  • « Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells », J. Pharmacol. Exp. Ther., vol. 260, no 2,‎ , p. 576–80 (PMID 1346637)
  • « Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics », Biochem. Pharmacol., vol. 45, no 11,‎ , p. 2352–4 (PMID 8100134, DOI 10.1016/0006-2952(93)90211-e)
  • « Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells », Mol. Pharmacol., vol. 35, no 4,‎ , p. 469–76 (PMID 2704370)
  • « Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland », Life Sci., vol. 64, no 25,‎ , p. 2351–8 (PMID 10374898, DOI 10.1016/s0024-3205(99)00188-5)
  • « Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity », J. Pharmacol. Exp. Ther., vol. 297, no 2,‎ , p. 790–7 (PMID 11303071)
  • « Antagonist binding profiles of five cloned human muscarinic receptor subtypes », J. Pharmacol. Exp. Ther., vol. 256, no 2,‎ , p. 727–33 (PMID 1994002)
  • « Binding profile of the selective muscarinic receptor antagonist tripitramine », Eur. J. Pharmacol., vol. 268, no 3,‎ , p. 459–62 (PMID 7805774, DOI 10.1016/0922-4106(94)90075-2)
  • « Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes », Pharmacotherapy, vol. 19, no 4,‎ , p. 447–51 (PMID 10212017, DOI 10.1592/phco.19.6.447.31041)
  • « Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications », Sleep Med Rev, vol. 17, no 4,‎ , p. 263–72 (PMID 23357028, DOI 10.1016/j.smrv.2012.08.001)
  • « [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine] », Encephale, vol. 28, no 4,‎ , p. 350–5 (PMID 12232544)
  • « Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram », Eur. J. Pharmacol., vol. 576, nos 1–3,‎ , p. 55–60 (PMID 17850785, PMCID 2231336, DOI 10.1016/j.ejphar.2007.08.017)
  • « Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor », J. Pharmacol. Exp. Ther., vol. 318, no 2,‎ , p. 657–65 (PMID 16675639, DOI 10.1124/jpet.106.103382, lire en ligne)
  • « Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo », Psychopharmacology, vol. 205, no 1,‎ , p. 119–28 (PMID 19337725, PMCID 2821721, DOI 10.1007/s00213-009-1521-8)
  • « Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology », Neuropsychopharmacology, vol. 28, no 8,‎ , p. 1400–11 (PMID 12784105, DOI 10.1038/sj.npp.1300203)
  • « Muscarinic mechanisms of antipsychotic atypicality », Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 27, no 7,‎ , p. 1125–43 (PMID 14642972, DOI 10.1016/j.pnpbp.2003.09.008)
  • « Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium », Eur. J. Pharmacol., vol. 390, no 3,‎ , p. 245–8 (PMID 10708730, DOI 10.1016/s0014-2999(00)00037-6)
  • « Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes », Biochem. Pharmacol., vol. 65, no 3,‎ , p. 435–40 (PMID 12527336, DOI 10.1016/s0006-2952(02)01515-0)
  • « Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders », Neuropsychopharmacology, vol. 25, no 6,‎ , p. 904–14 (PMID 11750183, DOI 10.1016/S0893-133X(01)00285-8)
  • « H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs », Neuropsychopharmacology, vol. 28, no 3,‎ , p. 519–26 (PMID 12629531, DOI 10.1038/sj.npp.1300027)
  • « Radioreceptor binding profile of the atypical antipsychotic olanzapine », Neuropsychopharmacology, vol. 14, no 2,‎ , p. 87–96 (PMID 8822531, DOI 10.1016/0893-133X(94)00129-N)

semanticscholar.org

unc.edu

kidbdev.med.unc.edu

  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )
  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )
  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )
  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )
  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )
  • Roth, BL et Driscol, J, « PDSP Ki Database », Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health (consulté le )